Microbiology of the human intestinal tract and approaches for its dietary modulation

Current Pharmaceutical Design

Volumn 15, Issue 13, 2009, Pages 1403-1414

  Saulnier, Delphine M ^a   Kolida, Sofia ^a   Gibson, Glenn R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; INULIN; MESALAZINE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; VSL3; LACTIC ACID DERIVATIVE;

ANTIBIOTIC ASSOCIATED DIARRHEA; ATOPY; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIUM CULTURE; BIFIDOBACTERIUM; CALCIUM ABSORPTION; CLINICAL TRIAL; COLON CANCER; CONSTIPATION; DENATURING GRADIENT GEL ELECTROPHORESIS; DIARRHEA; DIETARY INTAKE; DIGESTION; ENTERITIS; ENTEROPATHY; FLUORESCENCE IN SITU HYBRIDIZATION; FUNCTIONAL FOOD; GEL ELECTROPHORESIS; HUMAN; ILEITIS; IMMUNOSTIMULATION; INFECTIOUS DIARRHEA; INTESTINE ABSORPTION; INTESTINE DISCOMFORT; INTESTINE FLORA; INTESTINE INFECTION; LACTOBACILLUS; LACTOSE INTOLERANCE; MICROANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TRAVELLER DIARRHEA; ULCERATIVE COLITIS; ANIMAL; DRUG EFFECT; GASTROINTESTINAL TRACT; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; NUTRITION; PHYSIOLOGY;

ANIMALS; BIFIDOBACTERIUM; GASTROINTESTINAL TRACT; HUMANS; LACTATES; LACTOBACILLUS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PROBIOTICS;

EID: 67650573402     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209788168128     Document Type: Review

References (122)

1. Bennet R, Nord CE, Zetterstrom R, Transient colonisation of the gut of newborn infants by orally administered bifidobacteria and lactobacilli. Acta Paed 1992; 81: 784-7.
2. Mountzouris KC, McCartney AL, Gibson GR. Intestinal microflora of human infants and current trends for its nutritional modulation. Br J Nutr 2002; 87: 405-20.
3. Rathbone BJ, Heatley RV, Eds. Helicobacter pylori and Gastro-duodenal Disease, 2nd ed. Oxford: Blackwell Scientific Publications 1992.
4. Gibney MJ, Vorster HH, Kok FJ. Introduction to human nutrition. Oxford: Blackwell Scientific Publications 2002.
5. Geissler CA, Powers HJ. Human nutrition Churchill Livingstone: Oxford 2005.
6. Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998; 80: S209-12.
7. Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colori. J Appl Bacteriol 1991; 70: 443-59
8. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292:1115-8.
9. Gibson, G.R. & Roberfroid, M.B. Dietary modulation of the human colonic microbiota - Introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
10. Conway, P.L. Microbial ecology of the human large intestine. In: Gibson GR, Mecfarlane GT Eds, Human colonic bacteria. Role in Nutrition, Physiology and Pathology. Florida: CRC Press Inc, 1995; 1-24.
11. Moore WE, Holdeman LV. Human fecal flora: The normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974; 27, 961-79.
12. Suau A, Bonnet R, Sutren, Godon JJ, Gibson GR, Collins MD, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Env Microbiol 1999; 65: 4799-807.
13. Blaut M, Collins MD, Welling GW, Dore J, van Loo J, de Vos WM. Molecular biological methods for studying the gut microbiota: The EU human gut flora project. Br J Nutr Suppl 2002; 2: S203-11.
14. Franks AH, Harmsen HJM, Raangs GC, Jansen GJ, Schut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Env Microbiol 1998; 64: 3336-45.
15. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dote J. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 2000; 66: 2263-6.
16. Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan EE, de Vos WM, et al. Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 2005; 71: 4153-5.
17. Saunier K, Rouge C, Lay C, Rigottier-Gois L, Dore J. Enumeration of bacteria from the Clostridium leptum subgroup in human faecal microbiota using Clep 1156 16S rRNA probe in combination with helper and competitor oligonucleotides. Sys Appl Microbiol 2005; 28: 454-64.
18. Rochet V, Rigottier-Gois L, Rabot S, Doré J. Validation of fluorescent in situ hybridization combined with flow cytometry for assessing interindividual variation in the composition of human fecal microflora during long-tern storage of samples. J Microbiol Meth 2004; 59:263-70
19. Mitsuoka T. Taxonomy anal ecology of bifidobacteria. Bifid Microflora 1984; 1: 3-24.
20. Schultz M, Gottl C, Young RJ, Iwen P, Vanderhoof JA. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatric Gastroenterol Nutr 2004; 38: 293-7.
21. Park HK, Shim SS, Kim SY, Park JH, Park SE, Kim HJ, et al. Molecular analysis of colonized bacteria in a human newborn infant gut. J Microbiol 2005; 43: 345-53.
22. Stark PL, Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the 1st year of life. J Med Microbiol 1982; 15:189-203.
23. Penders, J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118: 511-21.
24. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69: S1035-45.
25. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001; 48: 198-205.
26. Saunier K, Dore J. Gastrointestinal tract and the elderly: Functional foods, gut microflora and healthy ageing. Digest Dis Sci 2002; 34: S19-24.
27. Chaia AP, Oliver G. Intestinal microflora and metabolic activity In: Fuller R, Perdigón G. Eds Gut flora, nutrition, immunity and health Oxford: Blackwell Publishers 2003; 77-98.
28. Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: Effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 1996; 81: 288-302.
29. Scardovi V, Trovatelli LD. The fructose-6-phosphate shunt as peculiar pattern of hexose degradation in the genus Bifidobacterium. Ann Microbiol 1965; 106: 1036-9.
30. Harmsen HJM, Wildeboer-Veloo ACM, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, et al Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Ped Gastroenterol Nutr 2000; 30: 61-7.
31. Campbell H, Jones I. Promoting breastfeeding: A view of the current position and a proposed agenda for action in Scotland. J Pub Health Med 1996; 18: 406-14.
32. Vanderhoof JA, Young PJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatric Gastroenterol Nutr 1998; 27: 323-32.
33. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diahrroea and shedding of rotavirus. Lancet 1994; 344: 1046-9.
34. Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001; 32: 1-7.
35. Bernet MF, Brassart D, Neeser JR, Servin AL. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interraction. Appl Environ Microbiol 1993; 59: 4121-8.
36. Gibson GR, Wang X. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous - culture. FEMS Microbiol Letts 1994; 118: 121-7.
37. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1995; 69: 1052S-7S.
38. McCracken VJ, Gaskins HR. Probiotics and the immune system. In Tannock GW Ed, Probiotics: A Critical Review. Wymondham Horizon Scientific Press 1999; 85-111.
39. Gilliland SE, Speck ML. Antagonistic effect of L. acidophilus toward intestinal and foodbourne pathogens in associative cultures. J Food Protect 1997; 40, 820-3.
40. Fernandes CF, Shahani KM, Amer MA. Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy-products. FEMS Microbiol Rev 1987; 46: 343-56.
41. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:106-11.
42. Metehnikoff E. The Prolongation of Life. London: William Heineman. 1907.
43. Nissle A. Weiteres uber grandlagen und praxis der mutaflorbe-handlung. Deutsche Medizinische Wochanschriff 1925; 44: 1809-13.
44. Shortt C, Living it up for dinner. Chem Ind 1998; 300-3.
45. Lilly DM, Stiwell RH. Probiotics: Growth promoting factors produced by microorganisms. Science 1965; 147: 747-8.
46. Fuller R. Probiotics in human medicine. Gut 1991; 32: 432-42.
47. FAO/WHO Working group report on drafting guidelines for the evaluation of probiotics in Food. Ontario: London 2002.
48. EFSA. Opinion of the Scientific Committee on a request from EFSA related to a generic approach to the safety assessment by EFSA of microorganisms used in food/feed and the production of food/feed additives. Request No EFSA-Q-2004-021 adopted on 15 April 2005. EFSA J 2005; 226: 1-12.
49. http://www.frost.com/prod/servlet/cpo/5652123
50. Temmerman R, Huys G, Pot B, Swings J. Identification and antibiotic resistance of isolates from probiotic products Abstracts of 101st ASM General Meeting 2001; C-289.
51. Sanders ME, Tompkins T, Heimbach JT, Kolida S. Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: regulatory considerations in Canada, E.U., and U.S. Eur J Nutr 2004; 44: 303-10.
52. Szilagyi A. Redefining lactose as a conditional prebiotic. Can J Gastroenterol 2004; 18: 163-7.
53. Marteau PR, Vesa T, Ramband J. Lactose maldigestion. In: Fuller, R, Ed, Probiotics. London: Chapman and Hall 1997; 65-88.
54. Isolauri E, Huurre A, Salminen S, Impivaara O. The allergy epidemic extends beyond the past few decades. Clin Exp Allergy 2004; 34: 1007-10.
55. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30: 1604-10.
56. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001; 357: 1076-9.
57. Viljanan M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics in the treatment of atopic eczema/ dermatitis syndrome in infants: A double-blind placebo-controlled trial. Allergy 2005; 60: 494-500.
58. Apostolou E, Pelto L, Kirjavainen PV, Isolauri E, Salminan SJ, Gibson GR. Differences in the gut bacterial flora of healthy and - milk hypersensitive adults, as measured by fluorescence in situ hybridisation. FEMS Immunol Med Microbiol 2001; 30: 217-21.
59. Pelto L, Isolauri E, Lilius EM, Nuutila J, Salminen S. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immanostimulatory effect in healthy subjects. Clin Exp Allergy 1998; 28: 1474-9.
60. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Ped 1999; 135: 564-8.
61. Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: A randomized, placebo-controlled trial. Mayo Clin Proc 2001; 76: 883-9
62. Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: A randomized double-blind placebo controlled trial. Alimen Pharmacol Ther 2005; 21: 583-90.
63. Boddy AV, Elmer GW, McFarland LV Levy RH. Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats. Pharm Res 1991; 8: 796-800.
64. Isolauri E, Juntunen M, Rautanen T, Sillanaukec P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991; 88: 90-7
65. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatric Res 1992; 32: 141-4.
66. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic-acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatric Gastroenterol Nutr 1995; 20:333-8.
67. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhea. Arch Dis Child 1995; 72: 51-3.
68. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004; 2: CD003048.
69. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Trav Med 1997; 1: 4143.
70. Kollaritsch von H, Holst H, Grobara P, Wiedermann G. Prophylaxe des Reisediarrhöe mit Saccharomyces boulardii. (Prevention of travelers' diarrhea by Saccharomyces boulardii. Results of a placebo-controlled double-blind study.). Fortschritte der Medizin 1993; 111: 153-6.
71. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 1997; 148: 567-75.
72. Fabia R, Ar'Rajab A, Johansson ML, Willen R, Andersson R, Molin G, et al. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scan J Gastroenterol 1993; 28: 155-62.
73. Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, Molin G, et al. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 1996; 111: 334-44.
74. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene- deficient mice. Gastroenterology 1999; 116: 1107-14.
75. Holma R, Salmenpera P, Lohi J, Vapaatalo H, Korpela R. Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on acotic acid-induced colitis in rots Scan J Gastroenterol 2001; 36: 630-5.
76. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon ATR. Non-pathogenic Escherichia coli versas mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet 1999; 354: 635-9.
77. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53: 1617-23.
78. Venturi A, Gionehetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, et al. Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis. Pharm Ther 1999; 13:1103-8.
79. Bibiloni R. Fedorak RN, Tannock GW, Madsen KL, Gionchetü P, Campieri M, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005; 100: 1539-46
80. Cremonini F, Talley NJ. Irritable bowel syndrome: Epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am 2005; 34: 189-204.
81. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal mieroflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 1231-8.
82. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299v in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001; 13:1143-7.
83. Brigidi P, Vital B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota ia patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001; 152: 735-41.
84. Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Pharm Ther 2003; 17: 895-904.
85. St-Onge MP, Farnworth ER, Jones PJH. Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism. Am J Clin Nutr 2000; 71: 674-81.
86. Hlivak P, Odraska J, Ferencik M, Ebringer L, Jahnova E, Mikes Z. One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratislavské lekárske Listy 2005; 106: 67-72.
87. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 2003; 86: 2452-61.
88. Gardiner GE, Heinemann C, Bruce AW, Beuerman D, Reid G. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol 2002; 9: 92-6.
89. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poelmer R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003; 35: 131-4.
90. Gibson GR, Probert HM, Van Loo J, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr Res Rev 2004; 17: 259-75.
91. Gibson GR, Berry Ottaway P, Rastall RA. Prebiotics: New Developments in Functional Foods. Oxford: Chandos Publishing Limited 2000.
92. Wang X, Gibson GR. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 1993; 75: 373-80.
93. Probert HM, Gibson GR. Investigating the prebiotic and gas-generating effects of selected carbohydrates on the human colonic microflora. Lett Appl Microbiol 2002; 35: 473-80.
94. Videla S. Deranged luminal pH homeostasis in experimental colitis can be restored by a prebiotic Gastmenterol 1999; 116: A942.
95. Videla S, Vilaseea J, Antolin M, Garcia-Lafuente A, Guarner F, Crespo E, et al. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol 2001; 96: 1486-93.
96. Cherbut C, Michel C, Lecannu G. The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr 2003; 133: 21-7.
97. Welters CF, Heineman E, Thunnissen FB, van den Bogaard AE, Soeters PB, Baeten CG. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rect 2002; 45:621-7.
98. Lewis S, Burmeister S, Cohen S, Brazier J, Awasthi A. Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea. Alimen Pharmacol Therap 2005; 21: 469-77.
99. Lewis S, Burmeister S, Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarthea: A randomized, controlled study. Clin Gastroenterol Hepatol 2005; 3: 442-8.
100. Cummings JH, Christie S, Cole TJ. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Alimen Pharmacol Ther 2001; 15: 1139-45
101. Pool-Zobel BL Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr 2005; 93: S73-90.
102. Delzenne N, Aertssens J, Verplaetse H, Roccaro M, Roberfroid M. Effect of fermentable fructo-oligosaccharides on mineral, nitrogen and energy digestive balance in the rat. Life Sci 1995; 57: 1579-87.
103. Roberfroid MB, Cumps J, Devogelaer JP. Dietary chicory inulin increases whole-body bone mineral density in growing male rats. J Nutr 2002; 132: 3599-602.
104. Coudray C, Fairweather-Tait SJ. Do oligosaccharides affect the intestinal absorption of calcium in humans? Am J Clin Nutr 1998; 68: 921-3.
105. van den Heuvel EG, Schoterman MH, Muijs T. Transgalactooligo-saccharides stimulate calcium absorption in postmenopausal women. J Nutr 2000; 130; 2938-42.
106. Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, et al. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr 2005; 82: 471-6.
107. Macfarlane S, Macfarlane GT, Cummings JH. Review article: Prebiotics in the gastrointestinal tract. Almen Pharmacol Ther 2006; 24: 701-14.
108. Zopf D, Roth S. Oligosaccharide anti-infective agents. Lancet 1996; 347: 1017-21.
109. Kolida S, Tuohy K, Gibson GR. Prebiotic effects of inulin and oligofructose. Brit J Nutr 2002; 87: S193-7.
110. Franks AH, Harmsen HJM, Raangs GC, Jansen GJ, Sehut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998; 64: 3336-45.
111. Welling GW, Elfferich P, Raangs GC, WildeboerVeloo ACM, Jansen GJ, et al. 16S ribosomal RNA-targeted oligonucleotide probes for monitoring of intestinal tract bacteria. Scan J Gastroenterol 1997; 32: 17-9.
112. Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, et al. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002; 68: 5445-51.
113. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 2004; 70: 7220-8.
114. Muyzer G, Smalla K. Application of denaturing gel gradient electrophoresis (DGGE) and temperature gel gradient electrophoresis (TGGE) in microbial ecology. An Van Leeuwen 1998; 73: 127-41.
115. McCartney AL. Application of molecular biological methods for studying probiotics and the gut flora. Br J Nutr 2002; 88: S29-37.
116. Ye RW, Wang T, Bedzyk L, Croker KM. Applications of DNA microarrays in microbial systems, J Microbiol Meth 2001; 47: 252-72.
117. Holloway AJ, van Laar RK, Tothill RW, Bowtell DD. Options available-from start to finish - for obtaining data from DNA microarrays II. Nat Gen 2002; 32: S481-9.
118. Molenaar D, Bringel F, Schuren FH, de Vos WM, Siezen RJ, Kleerebezem M. Exploring Lactobacillus plantarum genome diversity by using microarrays. J Bacteriol 2005; 187: 6119-27.
119. Pridmore RD, Berger B, Desiere F, Vilanova D, Barretto C, Pittet AC, et al. The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533. PNAS 2004; 101: 2512-7.
120. Altermann E, Russell WM, Azcarate-Peril MA, Barrangou R, Buck BL, McAuliffe O, et al. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. PNAS 2005; 102: 3906-12.
121. Wang RF, Beggs ML, Erickson BD, Cerniglia CE. DNA microarray analysis of predominant human intestinal bacteria in fecal samples. Mo Cell Probes 2004; 18: 223-4.
122. Wang RF, Beggs ML, Robertson LH, Cerniglia CE. Design and evaluation of oligonucleotide-microarray method for the detection of human intestinal bacteria in fecal samples. FEMS Microbiol Letts 2002; 213: 175-82.